» Articles » PMID: 38742243

Markers of Tissue Deterioration and Pain on Earth and in Space

Overview
Journal J Pain Res
Publisher Dove Medical Press
Date 2024 May 14
PMID 38742243
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Pain is an understudied physiological effect of spaceflight. Changes in inflammatory and tissue degradation markers are often associated with painful conditions. Our aim was to evaluate the changes in markers associated with tissue deterioration after a short-term spaceflight.

Patients And Methods: Plasma levels of markers for systemic inflammation and tissue degeneration markers were assessed in two astronauts before and within 24 h after the 17-day Axiom Space AX-1 mission.

Results: After the spaceflight, C-reactive protein (CRP) was reduced in both astronauts, while INFγ, GM-CSF, TNFα, BDNF, and all measured interleukins were consistently increased. Chemokines demonstrated variable changes, with consistent positive changes in CCL3, 4, 8, 22 and CXCL8, 9, 10, and consistent negative change in CCL8. Markers associated with tissue degradation and bone turnover demonstrated consistent increases in MMP1, MMP13, NTX and OPG, and consistent decreases in MMP3 and MMP9.

Conclusion: Spaceflight induced changes in the markers of systemic inflammation, tissue deterioration, and bone resorption in two astronauts after a short, 17-day, which were often consistent with those observed in painful conditions on Earth. However, some differences, such as a consistent decrease in CRP, were noted. All records for the effect of space travel on human health are critical for improving our understanding of the effect of this unique environment on humans.

Citing Articles

Low Back Pain During and After Spaceflight: A Systematic Review with Meta-Analysis.

Ceniza-Bordallo G, Zimmermann E, Vigouroux M, Niburski K, Fortin M, Ouellet J J Pain Res. 2024; 17:4103-4139.

PMID: 39660277 PMC: 11630706. DOI: 10.2147/JPR.S491060.

References
1.
Miller L, Fischer K, Goralnick S, Litt M, Burleson J, Albertsen P . Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology. 2002; 59(4):603-8. DOI: 10.1016/s0090-4295(01)01597-7. View

2.
Sugimoto C, Konno T, Wakao R, Fujita H, Fujita H, Wakao H . Mucosal-associated invariant T cell is a potential marker to distinguish fibromyalgia syndrome from arthritis. PLoS One. 2015; 10(4):e0121124. PMC: 4390316. DOI: 10.1371/journal.pone.0121124. View

3.
de Queiroz B, Pereira D, Lopes R, Felicio D, Silva J, de Britto Rosa N . Association Between the Plasma Levels of Mediators of Inflammation With Pain and Disability in the Elderly With Acute Low Back Pain: Data From the Back Complaints in the Elders (BACE)-Brazil Study. Spine (Phila Pa 1976). 2015; 41(3):197-203. DOI: 10.1097/BRS.0000000000001214. View

4.
Willie B, Zimmermann E, Vitienes I, Main R, Komarova S . Bone adaptation: Safety factors and load predictability in shaping skeletal form. Bone. 2019; 131:115114. DOI: 10.1016/j.bone.2019.115114. View

5.
Kinfe T, Muhammad S, Link C, Roeske S, Chaudhry S, Yearwood T . Burst Spinal Cord Stimulation Increases Peripheral Antineuroinflammatory Interleukin 10 Levels in Failed Back Surgery Syndrome Patients With Predominant Back Pain. Neuromodulation. 2017; 20(4):322-330. DOI: 10.1111/ner.12586. View